Weight change among patients engaged in medication treatment for opioid use disorder: a scoping review.

ABSTRACT: Background: Medication treatment for opioid use disorder (MOUD) is an instrumental tool in combatting opioid use and overdose. Excess weight gain associated with MOUD initiation is a potential barrier that is not well understood.Objectives: Conduct a scoping review of available studies investigating the effect of MOUD on weight.Methods: Included studies consisted of adults taking any type of MOUD (e.g. methadone, buprenorphine/naloxone, naltrexone) with data on weight or body mass index for at least two time points. Evidence was synthesized using qualitative and descriptive approaches, and predictors of weight gain including demographics, comorbid substance use, and medication dose were examined.Results: Twenty-one unique studies were identified. Most studies we

SUBMITTER: Carr MM 

PROVIDER: S-EPMC10840392 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature